期刊文献+

骨桥蛋白在反流性食管炎、Barrett食管及食管腺癌组织中的表达

Expression of osteopontin in reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma tissues
下载PDF
导出
摘要 目的研究骨桥蛋白(OPN)在反流性食管炎(RE)、Barrett’s食管(BE)、食管腺癌(EAC)及正常食管组织中的表达。方法经内镜活检获取组织标本,采用免疫组化和RT-PCR法检测RE、BE、EAC及正常食管组织中的OPN蛋白基因表达。结果 OPN在RE、BE及EAC组织中的表达均高于正常食管组织(P<0.05);OPN在BE和EAC组织中的表达无明显差异(P>0.05),且均高于RE组织(P<0.05)。结论 OPN蛋白在RE、BE及EAC组织中表达增高,可能与BE的发生和癌变有关。 [ Objective ] To investigate the expression of osteopontin in reflux esophagitis(RE), Barrett's esophagus (BE) and esophageal adenocareinoma (EAC) tissues. [ Methods ] The expression of osteopontin in RE, BE, EAC and normal esophageal tissues obtained by endoscopy biopsy was determined by immunohistochemistry and RT-PCR. [ Results ] The expressions of OPN in RE, BE and EAC tissues were higher than those in normal esophageal tissues (P 〈0.05); the expressions of OPN in BE and EAC tissues had no significant changes (P 〉0.05) and were higher than those in RE tissues (P 〈0.05). [ Conclusions ] High expression of OPN in RE, BE and EAC tissues may relate with the occurrence and canceratiou of Barrett's esophagus.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第16期24-27,共4页 China Journal of Modern Medicine
关键词 BARRETT食管 食管腺癌 反流性食管炎 骨桥蛋白 barrett's esophagus esophageal adenocarcinoma reflux esophagitis osteopontin
  • 相关文献

参考文献3

二级参考文献45

  • 1J Camilo Barreto,Mitchell C Posner.Transhiatal versus transthoracic esophagectomy for esophageal cancer[J].World Journal of Gastroenterology,2010,16(30):3804-3810. 被引量:16
  • 2Peng Ren,Zhen-Tao Yu,Li Xiu,Mei Wang,Hua-Min Liu.Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma[J].World Journal of Gastroenterology,2013,19(15):2412-2418. 被引量:2
  • 3Yuwei Zhang.Epidemiology of esophageal cancer[J].World Journal of Gastroenterology,2013,19(34):5598-5606. 被引量:81
  • 4侯晓华,郑丽端,王道蓉.Barrett食管的病因与流行病学[J].中华消化杂志,2006,26(2):114-115. 被引量:23
  • 5Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6:411-425.
  • 6Zhou XN, Wang LY, Chen MG, Wu XH, Jiang QW, Chen XY, Zheng J, Utzinger J. The public health significance and control of schistosomiasis in China=then and now. Acta Trap 2005; 96: 97-105.
  • 7Gryseels B, Polman K, Clerinx J, Kestens 1. Human schistosomiasis. Lancet 2006; 368: 1106-1118.
  • 8Boros D1. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev 1989; 2: 250-269.
  • 9Wilson MS, Mentink-Kane MM, Pesce jr. Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Bioi 2007; 85: 148-154.
  • 10Chapadeiro E, Pitanga LC. [On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study]. Rev Soc Bras Med Trap 1996; 30: 53-56.

共引文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部